These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 829206
1. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors. Manson LA. Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206 [No Abstract] [Full Text] [Related]
2. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice. Jose DG, Good RA. Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154 [No Abstract] [Full Text] [Related]
8. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice. Germain RN, Williams RM, Benacerraf B. Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167 [Abstract] [Full Text] [Related]
10. Immunologic responses to a murine mammary adenocarcinoma. II. Monocyte effector activation by humoral factors. Yamamura Y. Int J Cancer; 1977 May 15; 19(5):717-24. PubMed ID: 863548 [Abstract] [Full Text] [Related]
11. Murine natural anti-tumor antibodies. II. The contribution of natural antibodies to tumor surveillance. Chow DA, Wolosin LB, Greenberg AH. Int J Cancer; 1981 May 15; 27(4):459-69. PubMed ID: 6792086 [Abstract] [Full Text] [Related]
12. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target. Al-Rammahy AK, Levy JG. Cell Immunol; 1980 Dec 15; 56(2):338-46. PubMed ID: 6781763 [No Abstract] [Full Text] [Related]
13. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro. Song CW, Levitt SH. Radiology; 1974 Apr 15; 111(1):211-2. PubMed ID: 4205812 [No Abstract] [Full Text] [Related]
14. Development of tumors as a result of graft-versus-host reaction. Cornelius EA. Exp Hematol; 1973 Apr 15; 1(3):135-49. PubMed ID: 4153858 [No Abstract] [Full Text] [Related]
15. Immunologic responses to a murine mammary adenocarcinoma. I. Passive transfer of immunity by sera from tumor-bearing mice. Yamamura Y, Virella G, Haskill JS. Int J Cancer; 1977 May 15; 19(5):707-16. PubMed ID: 68018 [Abstract] [Full Text] [Related]
17. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells. Shellam GR, Knight RA. Nature; 1974 Nov 22; 252(5481):330-2. PubMed ID: 4372543 [No Abstract] [Full Text] [Related]
18. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse. Wolf JE, Faanes RB, Choi YS. J Natl Cancer Inst; 1977 May 22; 58(5):1407-12. PubMed ID: 67213 [Abstract] [Full Text] [Related]
19. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes. Rouse BT, Wagner H, Harris AW. J Immunol; 1972 May 22; 108(5):1353-61. PubMed ID: 4623947 [No Abstract] [Full Text] [Related]
20. Inhibition of tumor and fetal tissue growth in newborn recipients. Svet-Moldavsky GJ, Zinzar SN, Karmanova NV. Ann N Y Acad Sci; 1976 May 22; 276():328-42. PubMed ID: 194518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]